Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, formerly known by OMP-131R10, constitutes a new monoclonal immunoglobulin engineered to target granulocyte-macrophage colony-stimulating GM-CSF. Its mode of https://1684393-04-1800667.pointblog.net/text-94980077